Methods
The Norwegian Mother and Child Cohort Study (MoBa) is a prospective population-based pregnancy cohort study conducted by the Norwegian Institute of Public Health. 17 Pregnant women were recruited from all over Norway from 1999 to 2008 at approximately 18 gestational weeks. The participation rate was 41%, and all participants provided a written informed consent. Follow-up was conducted by mailed questionnaires at regular intervals.
The study is based on version VIII of the quality-assured data files released for research on February 14, 2014. In the current study, we use information from 6 questionnaires; the baseline questionnaire completed at approximately week 18 of pregnancy, questionnaires at child age 6, 18, and 36 months and 7 years, and the father's questionnaire (completed at recruitment; questionnaires are available at www.fhi.no/moba). Information gathered through questionnaires was linked to the Medical Birth Registry of Norway and the Norwegian Prescription Database (NorPD) using unique national identification numbers. The current study was approved by the Norwegian Data Inspectorate and the Regional Committee for Medical and Health Research Ethics of South-East Norway.
We included individuals with information from the questionnaire completed at 18 gestational weeks, in addition to questionnaire completed when the child was 6 and 18 months of age, who had reached age 7 years by December 31, 2013 (n = 41 020, Figure 1 ). We decided to use information about asthma medication from the NorPD as the primary outcome to reduce the impact of self-selection at age 7 years. Out of the parents who received the age 7-year questionnaire, 54% answered and returned it to MoBa. Characteristics of participants with missing exposure information up to age 18 months and, thus, not included are presented in Table I .
The primary outcome was current asthma at age 7 years as defined based on dispensed prescriptions in the NorPD, which contains information regarding all dispensed medications in Norway from January 2004 and onward, and classifies medications according to the Anatomical Therapeutic Chemical classification system. Medications classified as asthma medications were inhaled short-and long-acting beta2-agonists (R03 AC), inhaled corticosteroids (R03 BA), fixed-dose combinations of inhaled beta2-agonists and corticosteroids (R03 AK), and leukotriene antagonists (R03 DC). Children who had at least 1 dispensed prescription for asthma medications in the past year at the age of 7 years, in addition to a second dispensed prescription within 12 months of the first, were defined as asthma cases.
As secondary outcomes, we defined current asthma at age 3 and 7 years based on maternal report through questionnaires. Current asthma was defined based on maternal "yes, has now" in response to the question if the child suffered from asthma and reported use of inhaled glucocorticoids and/or beta2-agonists the last 12 months. Positive answers to both asthma diagnosis and use of medications were required for our definition of current asthma.
We classified children with asthma into 3 groups; early transient (asthma at only age 3 years), late-onset (asthma onset after age 3 years), and persistent asthma (asthma at both age 3 and Volume 195 • April 2018 7 years). These subanalyses were limited to those who returned questionnaires at both age 3 and 7 years.
In the 6-month questionnaire, ongoing breastfeeding or formula feeding from the first week in monthly intervals and age at introduction of solids was specified up until completion (median 27 weeks). From 6 to 18 months of age, the mothers reported whether they were breastfeeding in 4 intervals (6-8, 9-11, 12-14, and 15-18 months). The median value of each interval was used as a fixed value in calculations of breastfeeding duration. For the regression analyses, we divided duration of any breastfeeding in 3 categories (0-6, 6.1-11.9, and ≥12 months). Breastfeeding was defined as any breastfeeding regardless of whether the child had solids and/or formula.
A second aim was to study the effect of age at introduction of complementary foods (formula or solid foods). Solid complementary foods included porridge, bread or biscuits, fruit purees, and processed dinner. To determine this association, we included only children still breastfed at 6 months of age and divided them into 3 groups based on the age at which they were introduced to complementary foods, that is, children introduced to complementary foods before 4, 4-5.9, or 6 months of age or later. This exposure was defined to study the association with "full breastfeeding," though the current definition allows for water and vitamins, different from the strict definition of exclusive breastfeeding. In analyses of introduction of complementary foods, we also studied separately introduction of formula and solid foods. These subanalyses were only preformed in the primary group based on dispensed prescriptions in the NorPD.
Based on current literature, we chose a number of covariates because they have been associated with asthma in childhood and, additionally, may be associated with breastfeeding duration. 18 We extracted information about maternal age, birth weight, gestational age, parity, mode of delivery, and sex from the Medical Birth Registry of Norway. The first questionnaire completed around the 18th week of pregnancy held information about maternal education, prepregnancy body mass index (BMI) and smoking during pregnancy. The questionnaires at 6 and 18 months of age answered if the child had been in daycare outside home during the first 18 months of life. We also considered using pet ownership in the home as a confounder, but the questionnaires gave information limited to before 18 months of age.
Parental asthma and allergy were reported in the father's questionnaire and the mother's questionnaire at recruitment. Parental asthma was defined by the mother and/or father confirming ever having asthma. Parental allergy was defined by the father reporting ever having pollen allergy, and/or the mother reporting ever having pollen allergy or animal hair allergy. Other allergies (eg, food allergies) were not specified in the parental questionnaires and, therefore, not included in the parental allergy definition.
The covariates were divided in categories described in Table II (available at www.jpeds.com) and were used as categorical variables as possible confounders in the analyses.
Statistical Analyses
We used log-binomial regression models to obtain crude relative risks (RRs) in the main analysis. Multivariable analyses adjusted for the confounders selected a priori, and we used the robust variance estimator to account for potential clustering among siblings in the cohort. Similar analyses were conducted in the groups using only questionnaires. As subanalyses, we studied age-specific phenotypes of asthma with regression models for children with maternal report of asthma at the age of 3 and/or 7 years. We performed stratified analyses for children with and without maternal or paternal history of allergy and/or asthma, and we assessed possible interaction between breastfeeding and mode of delivery, sex, and maternal BMI. P values of <.05, or a 95% CI not including 1, were considered statistically significant. Analyses were performed using Stata 14 (StataCorp, College Station, Texas).
Results
Of the 41 020 eligible participants, 79% were still breastfed at 6 months of age and 38% for 12 months of age or longer. Duration of breastfeeding was positively associated with higher maternal age and education, parity, and vaginal delivery. In addition, mothers who continued breastfeeding longer tended to be nonsmokers, normal-weight and without history of asthma. The infants who were breastfed longer, started daycare outside home at an older age, and were less likely to be born premature or with low birth weight. Maternal and infant characteristics by duration of any breastfeeding are described in Table II .
Out of the 41 020 included, 31 930 (78%) were still breastfed at age 6 months. Of those breastfed at age 6 months, 78% had been introduced to solid foods and 36% were supplemented with formula before 6 months of age.
In the main analyses, 4.8% had asthma at age 7 years defined by dispensed asthma medications. The absolute risk of asthma was 5.9% among children breastfed up to 6 months, 4.6% from 6 up to 12 months, and 4.6% for 12 months or longer.
The risk of asthma for children with no or any breastfeeding <6 months compared with ≥12 months was increased before adjustments. However, in the adjusted analysis, we observed no significant differences among categories (Figure 2, A) . Analyzing breastfeeding with a finer categorization yielded similar results (adjusted RR [aRR] 0.99, 95% CI 0.96-1.02 for every 3-month increased duration, P value for trend .47). Maternal education and prepregnant BMI were the strongest confounders.
Analyses of age of introduction to complementary foods (formula and/or solid foods) in children still breastfed at 6 months of age showed a similar risk with introduction before 6 months of age compared with introduction at 6 months or later, and nonsignificant in adjusted analyses (Figure 2 , B, P value for trend .09). Association between asthma and breastfeeding at age 7 years based on NorPD. The analyses were adjusted for infant sex, birth weight, gestational age, parity, cesarean delivery, and start of daycare outside home and maternal age, smoking, BMI, education, and asthma. For age of introduction of complementary foods, only infants still receiving breastmilk at age 6 months were analyzed.
When looking at age for introduction of formula separately, the risk of asthma was increased when formula was introduced between 4 and 5.9 months of age compared with 6 months of age or later (aRR 1.21 [1.03-1.44]), but not for introduction <4 months (aRR 1.10 (0.98-1.25), P value for trend .08 (Table III ; available at www.jpeds.com).
The risk of asthma in children introduced to solid foods <4 months of age was increased before adjustments, however, there were no significant differences in the adjusted analyses (P value for trend .16, Table III ). Including age for solids and formula foods in the same model yielded similar risk estimates (data not shown).
We tested for interaction between breastfeeding and cesarean delivery and found no significant interactions for duration of breastfeeding (P = .23) nor for age at introduction of complementary foods (P = .10). We further tested for interaction between breastfeeding and sex, and found no significant interactions (P = .91 for duration of breastfeeding and 0.58 for age at introduction of complementary foods). Similarly, interaction was not found for breastfeeding and maternal BMI (P = .94 and .93, respectively).
In the secondary analyses limited to those who had returned questionnaires, the prevalence of asthma based on maternal report was similar to the main analyses, 5.2% at age 3 years, and 5.4% at age 7 years (absolute risk for each breastfeeding category shown in Figure 3) .
At the age of 7 years, questionnaire-based asthma diagnosis was not significantly associated with the duration of breastfeeding after adjustment for confounders. However, at age 3 years, the risk of asthma was significantly increased for children breastfed less than 6 months compared with 12 months or longer (Figure 3, A) .
The risk of maternal reported asthma at the age of 3 or 7 years was not associated with the age of complementary foods introduction after adjusting for confounders (Figure 3, B) .
For early transient asthma, we found a significantly increased risk for children breastfed less than 6 months compared with 12 months or longer (aRR 1.46 [1.15-1.84], Table IV ; available at www.jpeds.com). We observed no significant associations between duration of breastfeeding with lateonset asthma or persistent asthma. Age of introduction of complementary foods was not significantly associated with asthma in any of the 3 subgroups (Table V; available at www.jpeds.com).
We subsequently studied the potential influence of hereditary predisposition on the associations. If neither of the parents had allergies or asthma, we found a significantly increased risk of asthma at 7 years of age based on the NorPD in children with any breastfeeding less than 6 compared with ≥12 months of age (Table VI; available at www.jpeds.com) (P for interaction between breastfeeding and genetic predisposition = .043). We found no association between parental allergy and asthma Figure 3 . Secondary analyses (asthma at age 3 and 7 years based on maternal report). The analyses were adjusted for infant sex, birth weight, gestational age, parity, cesarean delivery, and start of daycare outside home and maternal age, smoking, BMI, education, and asthma. For age of introduction of complementary foods, only infants still receiving breastmilk at age 6 months were analyzed.
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and age of introduction of complementary foods, and no significant interaction (P = .21).
We studied the potential influence of breastfeeding with stratification of maternal and paternal allergy/asthma separately, as a potential effect has been hypothesized to be mediated through breast milk factors. The associations with breastfeeding duration were similar in the stratum with no maternal compared with no paternal asthma/allergy (Table VI) .
Discussion
The current nationwide prospective study suggests that duration of breastfeeding is not associated with asthma at age 7 years. Weaning before 6 months of age was associated with increased risk of asthma at age 3 years. Age at introduction of complementary foods in general was not a predictor of asthma neither at age 3 nor 7 years, though formula before 6 months of age was not a consistent risk factor.
Among strengths of the current study is the large sample size from a general population and the prospective data collection that minimizes potential recall bias. Frequent questionnaires during the child's first years of life reduce the time between exposure and data collection and increases the accuracy of the data. We were able to adjust for a number of potential confounders, among this detailed parental background information collected before the birth of the child. This reduces the risk of overestimating beneficial effects because breastfeeding is highly influenced by other healthy choices. The high prevalence of breastfeeding in the study limits the power to study the subgroup who did not receive breastmilk, but it provides a good opportunity to study duration of breastfeeding and the introduction of complementary foods.
A potential weakness in our study is the risk of reverse causality. 19 Symptoms of early wheezing or atopic eczema may occur already during breastfeeding and may impact the mother's motivations for breastfeeding. 20 In the subanalysis of lateonset asthma, this potential for reverse causality should be minimal. The accuracy of the asthma diagnosis is a further limitation, as we do not have access to individual medical records to verify the diagnosis. However, the strict diagnostic criteria applied for current asthma should reduce the risk of misclassification.
Parental history of atopy may similarly influence the duration of breastfeeding. We, thus, adjusted for the potential confounding effects of maternal asthma. Adjusting for maternal education and BMI changed the associations substantially. These confounding factors, likely to be markers of a healthy life style, are important to include in future studies regarding potential effects of breastfeeding. Previous studies differ considerably in the extent of access to such confounders, and this may explain the conflicting results. 13 Both the participation rate into the MoBa cohort and loss to follow-up may have resulted in selection bias. 21 In our study, we observed a greater loss of follow-up in children of mothers with less education and mothers who smoked during pregnancy. Both of these are risk factors for asthma in our study, which may influence the risk estimates in our analyses. To reduce the impact of this self-selection, we decided to define asthma at age 7 years by the NorPD, which holds information on all dispensed prescriptions for Norwegian pharmacies since 2004. The prevalence of asthma as defined through NorPD was similar for included (4.8%) and excluded (5.0%). The NorPD asthma definition included inhalation steroids. Use of this medication for other causes (eg, recurrent pseudocroup, bronchopulmonary dysplasia, eosinophilic esophagitis) may occur, but to a very limited extent.
Our observations are consistent with the findings in the Avon Longitudinal Study of Pregnancy and Childhood (ALSPAC) cohort, where lower risk of early wheezing with longer duration of breastfeeding did not extend into later childhood (age 7.5 years). 22 In the study from the Generation R cohort, neither duration nor exclusivity of breastfeeding was associated with asthma at age 10 years, though some differences in lung function were found. 23 Also in the Promotion of Breastfeeding Intervention Trial (PROBIT) cluster randomized trial, Kramer et al found no indication of reduced risk of asthma at age 6.5 years in a group of children with significantly longer duration and exclusivity of breastfeeding compared with the control group with less breastfeeding. 24 However, in a review and meta-analysis from 2015, Lodge et al found a reduced risk of asthma associated with more vs less breastfeeding in ages 5-18 years. 13 This meta-analysis also includes cross-sectional and case-control studies, which seem to show a greater protective effect than cohort studies, possibly because of recall bias. In line with this assumption, the metaanalysis did not find an association between breastfeeding and asthma when limiting the pooled estimated association to cohort studies.
In our cohort, the prevalence of current asthma at age 7 years was 5%, lower than the 10%-11% prevalence reported from other cohorts in Norway, 25, 26 but more similar to a Swedish cohort. 27 We have applied a strict definition of asthma as the primary outcome, with asthma medications dispensed twice or more the last 12 months, and the comparable studies have slightly different criteria. In addition, the mothers consenting to the MoBa study have in general higher socioeconomic status and lower rates of smoking. This cohort may, thus, not be comparable with the general population for prevalence studies. However, the associations between exposure and disease have been shown to be robust to this selection bias. 21 In the Swedish cohort, Kull et al found an inverse association of breastfeeding with both early transient asthma and persistent asthma, although there was no association with lateonset asthma. 27 In line with these observations, we also found lower prevalence with longer duration of breastfeeding in early transient asthma (3 years of age). Wheezing before this age is often caused by respiratory virus infections, and some of the previous studies have indicated that breastfeeding may provide protection against viral lower respiratory tract infections. [28] [29] [30] In our study, the age of introduction of complementary foods was not associated with asthma at age 3 or 7 years. Other studies have also shown that delaying the introduction of common weaning foods beyond 4 or 6 months of age is unlikely to reduce the likelihood of asthma. [31] [32] [33] In the current study, the association between duration of breastfeeding and asthma differed by genetic predisposition (parental history of asthma). Previous studies have also investigated how maternal asthma or parental allergy influences the association between breastfeeding and asthma. [34] [35] [36] With a longer duration of breastfeeding, Oddy et al found a decreased risk of asthma in children aged 6 years, regardless of whether the mother had asthma. 35 Scholtens et al found that breastfeeding was associated with a lower risk of asthma in children aged 8 years, without evidence of effect modification by the family history of allergy. 36 Rothenbacker et al found an inverse association for duration of breastfeeding and the risk for asthma in children aged 2 years, especially in children of mothers without a history of atopic disease. 34 Similar to our findings, this study may indicate that environmental factors such as early feeding may be of more importance in children with low heredity for asthma. None of these studies are directly comparable due to different categorizations of breastfeeding, age of the children, and definitions used for asthma.
In this large, prospective birth cohort, we found no association between asthma at age 7 years and duration of any breastfeeding. Early introduction of complementary foods did not influence the association. Subanalyses indicated that breastfeeding was associated with reduced risk in children with a low family risk of asthma. ■ 
